Cresset Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,659
| Closed | -$423K | – | 1882 |
|
|
2023
Q3 | $423K | Sell |
3,659
-1,057
| -22% | -$122K | ﹤0.01% | 1229 |
|
|
2023
Q2 | $485K | Buy |
4,716
+1,371
| +41% | +$141K | ﹤0.01% | 1165 |
|
|
2023
Q1 | $365K | Buy |
+3,345
| New | +$365K | 0.01% | 572 |
|
|
2022
Q4 | – | Sell |
-5,130
| Closed | -$317K | – | 931 |
|
|
2022
Q3 | $317K | Sell |
5,130
-197
| -4% | -$12.2K | ﹤0.01% | 654 |
|
|
2022
Q2 | $422K | Buy |
5,327
+1,713
| +47% | +$136K | 0.01% | 613 |
|
|
2022
Q1 | $381K | Buy |
3,614
+711
| +24% | +$75K | ﹤0.01% | 692 |
|
|
2021
Q4 | $313K | Sell |
2,903
-693
| -19% | -$74.7K | ﹤0.01% | 867 |
|
|
2021
Q3 | $393K | Buy |
3,596
+1,175
| +49% | +$128K | 0.01% | 718 |
|
|
2021
Q2 | $227K | Buy |
+2,421
| New | +$227K | ﹤0.01% | 901 |
|
|
2019
Q2 | – | Sell |
-20
| Closed | -$1K | – | 2069 |
|
|
2019
Q1 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 1952 |
|